Matching slides 58,039
Current window 36,151-36,180
Pages 1,935
Rows per page 30
Slide function: Analyze Dataclear collectionreset all

Slide function

36,151-36,180 of 58,039

filter-aware
13
The slide highlights a 50% improvement in valuation multiple despite a decline in the NBI index multiple.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Before After1 hit
17
The table categorizes products into 'Proprietary' and 'Royalty' streams.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Mece Breakdown1 hit
18
The slide uses a mix of bar charts for annual revenue and a line chart for weekly prescription growth.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Mece Breakdown1 hit
19
The slide uses a bar chart to show quarterly net sales growth from Q4'21 to Q1'23.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Mece Breakdown1 hit
20
The slide uses donut charts to represent revenue composition and growth.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & ProofLoop · Mece Breakdown1 hit
23
The chart uses a break in the x-axis to transition from historical data (2020-2022) to future projections (2024-2025).Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
52
Values are in millions, unaudited.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
53
Financial disclosure table for Alkermes.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
54
Includes footnotes regarding weighted average shares and specific adjustments like share-based compensation, depreciation, and amortization.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
55
Includes a footnote regarding arbitration proceedings with Janssen Pharmaceutica N.V.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
11
The slide uses a split layout with charts on the left and key takeaways on the right.Allego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
12
The slide uses a split layout with charts on the left and key takeaways on the right.Allego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
15
The table provides a bridge between statutory loss and non-IFRS metrics like EBITDA and Free Cash Flow.Allego | Results Presentation Deck | 16 slides · Allego
Conference presentation Investor relations Beat · Action1 hit
07
The slide uses a central bar chart flanked by four strategic callout boxes.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · Key Takeaways1 hit
15
The slide combines immunofluorescence microscopy (left) with physiological data (right) to demonstrate the mechanism of action and therapeutic efficacy.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · RoadmapLoop · Quick Win Big Bet1 hit
06
Includes primary endpoint noninferiority data and secondary responder metrics.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
25
The chart combines a bar chart for sales volume and a line chart for average sales price. The right side uses a vertical gradient arrow to show relative performance of returning visitor percentages.Aston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations 1 hit
33
The chart displays dual Y-axes for Torque and Power, comparing two vehicle models across engine speed.Aston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations Beat · Product1 hit
34
The slide uses two line charts to demonstrate improved vehicle dynamics and powertrain software tuning.Aston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations Beat · Product1 hit
57
The slide uses a tabular layout with circular data markers to emphasize growth.Aston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations Beat · Financials1 hit
60
Aston Martin Lagonda | Investor Day Presentation Deck | 66 slidesAston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations Beat · Financials1 hit
61
The chart uses a waterfall bridge format to explain margin expansion.Aston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations Beat · Financials1 hit
62
The slide highlights the strategic pivot from internal combustion engines to battery electric vehicles.Aston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations Beat · Financials1 hit
06
The slide uses a combination of stacked bar charts for revenue composition and a horizontal bar chart for growth metrics.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
13
Kaplan-Meier survival curves showing primary (2020) and updated (2023) analysis results.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
14
Includes Kaplan-Meier survival curve and 'number at risk' table.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
15
Clinical trial data visualization (Kaplan-Meier plot).AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
16
The slide displays a Kaplan-Meier survival analysis with a corresponding 'number at risk' table and key statistical metrics (HR, CI, p-value).AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
17
Standard forest plot used in clinical trial reporting.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
18
Includes two distinct data cut-off dates for different parts of the safety summary.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit